SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
SNNA
Delisted
SNNA was delisted on the 16th of December, 2019.
54 hedge funds and large institutions have $151M invested in Sienna Biopharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
54
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.27M | |
| 2 | +$1.65M | |
| 3 | +$1.12M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$996K |
| 5 |
BlackRock
New York
|
+$443K |
Top Sellers
| 1 | -$2.74M | |
| 2 | -$1.5M | |
| 3 | -$732K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$421K |
| 5 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$372K |